Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in PALI — Palisade Bio, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to PALI Full portfolio

Position in PALI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$262,435
+$262,386 QoQ
Shares Held
125,567
+597838.1% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 124 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PALI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. PALI ranks #229 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in PALI

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $262,435 125,567
2025-12-31 $49 21
2025-09-30 $18 21
2025-06-30 $14 21
2025-03-31 $14 21
2024-12-31 $34 21
2024-09-30 $74 21
2024-06-30 $94 21
2024-03-31 $164 411
2023-12-31 $226 384
2023-09-30 $211 366
2023-06-30 $631 372
2023-03-31 $1,178 335
2022-12-31 $1,736 334
2022-09-30 $1,666 16,684
2022-06-30 $6,708 16,366
2022-03-31 $17,281 16,304
2021-12-31 $8,187 6,300
2021-09-30 $16,666 6,290
2021-06-30 $975 240